The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Gluten Sensitivity Formula
Lycopodium Clavatum, Pulsatilla · LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mg; PULSATILLA VULGARIS 12 [hp_X]/mg · Capsule · Oral · The Wise Alternative
NDC 51096-0001-01 · 180 mg in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Lycopodium Clavatum, Pulsatilla (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| The Wise Alternative | LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mg; PULSATILLA VULGARIS 12 [hp_X]/mg | Aug 6, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Gluten Sensitivity Formula — NDC 51096-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51096000101.
Free to cite with attribution — see how the data is put together.